Intellectual Property

Patent rights in the U.S., Europe, Japan, Australia, Canada, Singapore, China, India, Hong Kong and Brazil
• 25 issued patents
• 29 pending applications

Patent portfolio of (7) patent families including:
- BPZE strains
- BPZE vaccines for the prevention of Whooping Cough
• Influenza Cross-protection
- Asthma and Allergy treatment/prophylaxis
• New BPZE1 strains

 

Origin

Name

Patent no.

Date Issued

France

Method of using attenuated Bordetella strains

2840319

Dec 5, 2003

India

Live attenuated Bordetella strains as a single dose vaccine against whooping cough

270798

Mar. 7, 2007

China

Live attenuated Bordetella strains as a single dose vaccine against whooping cough

ZL2009801609531

Sept. 20, 2007

Europe

Influenza vaccine, composition, and methods of use

PCT/IB2009/007153

Jun. 15 2009

Australia

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2010243708

Apr. 28, 2009

Austrailia

Influenza vaccine, composition, and methods of use

2009348207

June 15, 2009

Europe

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

PCT/EP2010/055507

Apr. 26, 2010

Japan

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2012-507703

Apr. 26, 2010

Singapore

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2011078771

Apr. 26, 2010

Canada

Influenza vaccine, composition, and methods of use

2765364

Dec. 23, 2010

Japan

Method of using attenuated Bordetella strains

2012-530128

Nov. 29 2012

Australia

Live attenuated Bordetella strains as a single dose vaccine against whooping cough

2007224734

Mar. 20, 2013

Europe

Live attenuated Bordetella strains as a single dose vaccine against whooping cough

1994139

July 7, 2013

China

Method of using attenuated Bordetella strains

CN101400783B

Mar. 3 2013

Japan

Influenza vaccine, composition, and methods of use

2013-524092

Apr. 4, 2013

Japan

Live attenuated Bordetella strains as a single dose vaccine against whooping cough

2012-5151774

May 30, 2014

Canada

Influenza vaccine, composition, and methods of use

2,765,364

May 26, 2015

U.S.

Live attenuated Bordetella strains as a single dose vaccine against whooping cough

9,119,806

Sep. 1 2015

U.S.

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

8,986,709

Mar. 24, 2015

U.S.

Method of using attenuated Bordetella strains

9,180,178

Nov. 10 2015

Japan

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2012-567803

Jan 1, 2015

U.S.

Recombinant Bordetella Strains

9,528,086

Dec. 27, 2016

Japan

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2014-105874

Sept. 2 2016

U.S.

Influenza vaccine, composition, and methods of use

9,526,778

Dec. 27, 2016

U.S.

Adenylate cyclase deficient bordetella strains

9,655,959

May 23, 2017